Grants-Funding

Target ALS announced today the grantees receiving funding for new projects focused on ALS biomarker discovery and development, resulting from a call for proposals issued in the spring. In accordance with the requirements of the Target ALS grantmaking process, collaboration between ...

Thousands of American troops who were deployed in the First Gulf War were exposed to a variety of chemicals that resulted in psychological and physiological symptoms that health experts call Gulf War illness (GWI), previously called Gulf War...

The rapid rise in the aging population worldwide underscores the necessity to find strategies to promote healthy longevity. Previous research has shown that transfusing old animals with blood from young animals reverses some aspects of aging...

Natalia Higuita-Castro, assistant professor in the Department of Biomedical Engineering, is the lead investigator for one of eleven projects awarded funding to boost research in response to the COVID-19

More than $3.7 million was awarded to Mahesh Mohan, DVM, MS, Ph.D., Professor at the Texas Biomedical Research Institute, and Chioma M. Okeoma, Ph.D., Associate Professor at Stony Brook...

The Grupo Español de Investigación e Innovación en Vesículas Extracelulares (GEIVEX) the German Society for Extracellular Vesicles (GSEV), the United Kingdom Society for Extracellular Vesicles (UKEV)...

Cancer researchers operate from a fundamental premise: Tumor cells are very smart. Because of their ability to disguise themselves, hide or otherwise evade the immune cells that can kill them, the key to successful treatment depends upon...

Dr. Blake Johnson, assistant professor of biology at Ouachita Baptist University, has been awarded a $75,000 grant from the University of Arkansas for Medical Sciences’ (UAMS) Arkansas Breast Cancer...

The Cancer Prevention and Research Institute of Texas, CPRIT, awarded Texas A&M AgriLife’s Jean-Phillippe Pellois, Ph.D., with a $200,000 grant for his project, “Mechanisms of Exosomal Cell Entry and...

Aethlon Medical, Inc a therapeutic technology company focused on unmet needs in global health, announced today that the National Cancer Institute (NCI) has awarded the Company an SBIR Phase 2...